{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T18:16:12Z","timestamp":1725646572862},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.clinthera.2013.05.001","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T10:09:57Z","timestamp":1371809397000},"page":"862-869","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetic Properties of Once-Daily Oral Low-Dose Mesylate Salt of Paroxetine (LDMP 7.5 mg) Following Single and Multiple Doses in Healthy Postmenopausal Women"],"prefix":"10.1016","volume":"35","clinical-trial-number":[{"clinical-trial-number":"nct01829919","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"M.","family":"Cristina Castelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sailaja","family":"Bhaskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Lippman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.05.001_bib1","first-page":"11","article-title":"Treatment of menopause-associated vasomotor symptoms: position statement","volume":"2","author":"The North American Menopause Society","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.clinthera.2013.05.001_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.maturitas.2007.09.006","article-title":"Healthcare seeking and treatment for menopausal symptoms in the United States","volume":"58","author":"Williams","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.clinthera.2013.05.001_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/13697130701744696","article-title":"Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States","volume":"11","author":"Williams","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.clinthera.2013.05.001_bib4","unstructured":"US National Institutes of Health. NIH state-of-the-science conference statement on management of menopause-related symptoms, 2005:21\u201323. http:\/\/consensus.nih.gov\/2005\/menopausestatement.pdf. Accessed December 20, 2012."},{"key":"10.1016\/j.clinthera.2013.05.001_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of the North American Menopause Society","volume":"19","author":"North American Menopause Society","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.clinthera.2013.05.001_bib6","unstructured":"North American Menopause Society. Hormone therapy statistics, 2011. http:\/\/www.menopause.org\/publications\/clinical-practice-materials\/Htstatistics. Accessed September 13, 2012."},{"key":"10.1016\/j.clinthera.2013.05.001_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/14656560903451708","article-title":"Paroxetine mesylate: comparable to paroxetine hydrochloride?","volume":"11","author":"Pae","year":"2010","journal-title":"Exp Opin Pharmacother"},{"key":"10.1016\/j.clinthera.2013.05.001_bib8","unstructured":"Pexeva (paroxetine mesylate) tablets [prescribing information]. Miami, Fla: Noven Therapeutics; 2012."},{"key":"10.1016\/j.clinthera.2013.05.001_bib9","unstructured":"Joffe H. Low-dose mesylate salt of paroxetine (LDMP) in treatment of vasomotor symptoms (VMS) in menopause. Presented at: Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; May 5\u20139, 2012; San Diego, Calif."},{"key":"10.1016\/j.clinthera.2013.05.001_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/13697137.2011.608596","article-title":"Menopausal hot flushes and night sweats: where are we now?","volume":"14","author":"Archer","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.clinthera.2013.05.001_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajhb.1077","article-title":"Physiology of hot flashes","volume":"13","author":"Freedman","year":"2001","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.clinthera.2013.05.001_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2005-869479","article-title":"Pathophysiology and treatment of menopausal hot flashes","volume":"23","author":"Freedman","year":"2005","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.clinthera.2013.05.001_bib13","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2013.05.001_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10401230209147454","article-title":"Long-term side effects of newer-generation antidepressants: SSRIs, venlafaxine, nefazodone, bupropion, and mirtazapine","volume":"14","author":"Masand","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2013.05.001_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0447.1989.tb07176.x","article-title":"A review of the metabolism and pharmacokinetics of paroxetine in man","volume":"350","author":"Kaye","year":"1989","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.clinthera.2013.05.001_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2125.2006.02629.x","article-title":"Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling","volume":"61","author":"Feng","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2013.05.001_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.05.001_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/dmd.109.030551","article-title":"Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator","volume":"38","author":"Jornil","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.05.001_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199700321-00003","article-title":"Clinically relevant pharmacology of selective serotonin reuptake inhibitors: an overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism","volume":"32","author":"Preskorn","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2013.05.001_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/00912700022008702","article-title":"CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations","volume":"40","author":"Alfaro","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2013.05.001_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/clpt.1992.23","article-title":"The relationship between paroxetine and the sparteine oxidation polymorphism","volume":"51","author":"Sindrup","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.05.001_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1124\/dmd.31.3.289","article-title":"Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine","volume":"31","author":"Bertelsen","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinthera.2013.05.001_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/clpt.1992.24","article-title":"Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphism","volume":"51","author":"Sindrup","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.05.001_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-004-0792-6","article-title":"Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine","volume":"60","author":"Sawamura","year":"2004","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181300235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181300235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T23:30:30Z","timestamp":1539559830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929181300235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S014929181300235X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.05.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}